申请人:Klein Markus
公开号:US20130217670A1
公开(公告)日:2013-08-22
Compounds of the formula I in which R, R
1
and R
2
have the meanings indicated in Claim
1
, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumours.
公式I中,R、R1和R2具有Claim1中所示的含义的化合物是PI3K抑制剂,可以用于自身免疫性疾病、炎症、心血管疾病、神经退行性疾病和肿瘤的治疗等领域。